Director/Senior Associate Director, Medical Affairs Strategy Team Member - Pulmonary ILD (Hybrid)

Duties & Responsibilities Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for pulmonary fibrosis products/indications that prioritize innovation and address meaningful gaps internally and externally. Leads the indication- or product-specific co-creation with corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensures US strategic business needs are fully integrated into the global IBPs. Leads the creation of the respective US Medical Affairs Plans (MAP’s) and implements Launch Excellence tactics in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence. Effectively drives the execution of medical tactics, key data release activities, stays abreast of paradigm shifts in clinical practice, and aligns with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare landscape. Identifies and promotes synergies throughout the product lifecycle by influencing the US TAs, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders. Proactively partners with the Medical Affairs Strategy Executive Director to ensure seamless collaboration with the Clinical Development Lead and the Early Asset TA Lead to facilitate full integration of the prioritized US clinical practice dynamics into the Clinical Development programs. Drives success in TA launches and timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership. Serves as a key representative in strategic discussions with TAs and CDMA Leadership regarding pulmonary fibrosis products to maximize business opportunities from a medical perspective, identify risks, assess the competitive landscape, and ensure appropriate collaboration occurs with various business functions. Leads the integration of insights, planning, execution, and analysis of evidence programs, creation and enhancement of content resources, maximizes medical communication channels and Strategic Engagement program with key experts, scientific leaders, and key institutions. Ensures strategic congress planning, medical education, advisory boards, publication strategies, scientific advancement grants, and interfaces with professional societies relevant to pulmonary fibrosis products. Ensures availability of prioritized content, and develops and tracks associated measurable business outcomes. Proactively engages with Medical Customer Experience, A&I, and Capability Excellence teams to ensure seamless planning. Actively contributes at and represents the CDMA TA team in internal business planning workshops and relevant strategic planning governance regarding pulmonary fibrosis products to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., KPIs, metrics). Leads proactive and ad‑hoc TA specific US projects to drive key strategic initiatives that facilitate business agility, customer focus and ensure compliance standards are met. Leverages CDMA resources to create tailored tools and material to address organized customers, Payers/Systems in support of the Account Medical Advisors (AMA’s). Co‑creates an aligned strategic framework for organized customers in collaboration with the Value/Access and Health‑Systems marketing teams. Ensures coordinated communication plan for Payers/Systems across the relevant internal stakeholders with emphasis on leading the medical affairs aspects of these plans. Requirements Bachelor’s degree required, and in addition fulfill one of the following education levels: Advanced degree (PharmD, NP, PA, Master’s, M.D., DO, Ph.D.) Combined BSc. with an MBA, or BSN with an MBA Other medically qualified licensure (e.g., RPh, Respiratory Therapist) Ten (10) years of professional experience in a scientific, clinical, and/or medical space, including seven (7) years in a relevant position in pharmaceutical or related industry. Three-plus (3+) years’ experience in Medical Affairs supporting a relevant therapeutic area. Experience in medical/scientific dialogue with Health Systems and Payers strongly preferred. Demonstrated experience with pharmaceutical drug development and the use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation. Ability to collaborate, influence, and lead with executive presence, establishing strategic direction, driving execution, creating compelling communications and providing a global perspective. Ability to translate scientific and medical market insights into medical tactical plans for effective launches of pharmaceutical products in the US, integrated evidence generation plans, and optimized medical strategies. Demonstrated ability to collaborate cross-functionally to enable successful execution and deliver results in a deadline-driven environment while managing multiple priorities. Deep understanding of Pulmonary ILD therapeutic area(s), shifting US healthcare environment, medical, pharmaceutical and payor market dynamics, portfolio growth, and ability to manage multiple projects and identify risks in a fast‑paced environment with a drive for results and sense of urgency to meet medical market needs. Ability to travel with some overnights away from home as required by the nature of the role. Eligibility Requirements Must be legally authorized to work in the United States without restriction. Must be willing to take a drug test and post‑offer physical (if required). Must be 18 years of age or older. Compensation The base salary range for this position is $250,000 to $394,000. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job‑related factors such as skills, experience, and qualifications, and other factors permitted by law. For an overview of our benefits please click here. #J-18808-Ljbffr Boehringer Ingelheim